resectable


Also found in: Thesaurus, Medical.
Related to resectable: Resectable cancer

re·sect

 (rĭ-sĕkt′)
tr.v. re·sect·ed, re·sect·ing, re·sects
To perform a resection on.

[Latin resecāre, resect-, to cut back : re-, re- + secāre, to cut; see sek- in Indo-European roots.]

re·sect′a·bil′i·ty n.
re·sect′a·ble adj.

resectable

(rɪˈsɛktəbəl)
adj
able to be resected
Translations

resectable

adj resecable, extirpable
Mentioned in ?
References in periodicals archive ?
Our lead product is MBFT-201, a canine melanoma vaccine for dogs with Stage II/III resectable disease.
M2 PHARMA-October 26, 2017-Apexigen and UCSF Collaborate in Clinical Trial Evaluation of APX005M in Resectable Esophageal and Gastroesophageal Junction Cancers
As part of the trial, the company will evaluate its CD40 agonistic antibody, APX005M, in combination with multimodal treatment (chemotherapy and radiation therapy) in patients with resectable esophageal and gastro-esophageal junction cancers.
Intramedullary cavernomas are easily resectable tumours from surrounding haemosidrin bed and have a very good surgical outcome.
Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers.
Spleen-preserving D2 resection is recommended as a standard care of resectable gastric cancer in specialised centers.
sup][1] Notably, only 20% of patients with stage IV colon cancer with unresectable synchronous liver-only-metastases (CLM) present with resectable lesions at diagnosis.
However, in one systematic meta-analysis study, adjuvant chemotherapy for localized resectable soft-tissue sarcoma exists marginal survival benefit [4], implying that chemotherapy may have a role in selected MPNST patients.
Ipilimumab, a monoclonal antibody that blocks cytotoxic T-lymphocyte antigen 4 (CTLA-4), was initially approved in 2011 for the treatment of un resectable or metastatic melanoma.
The European dimension of the project lies in the validation of the biomarker signature that will make it possible for the first time to accurately diagnose pancreatic cancer in an asymptomatic stage (I and II) when the cancer is resectable.
The benefits of neoadjuvant chemotherapy, according to studies, are tumor reduction, local control, decreased recurrence, decreased distant metastasis, organ preservation in resectable tumors, less need of postoperative radiotherapy, less need for mandibulectomy, and 4%-6% increase in survival rate.